| Filed On | Filing |
|---|---|
| 27 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure
Independent Director and Seasoned Healthcare Executive Walt Rosebrough |
| 17 Sep 2026 |
Form 4: Kurzius Lawrence Erik, Director
Bought 10,000 shares ($549K) |
| 15 Sep 2026 |
Form 4: Keel Paul A, Director
Bought 4,701.015 shares ($250K) |
| 15 Sep 2026 |
Form 4: Rosebrough Walter M Jr, Director
Bought 7,000 shares ($379K) · Bought 3,000 shares ($163K) |
| 15 Sep 2026 |
Form 4: Kurzius Lawrence Erik, Director
Bought 10,000 shares ($539K) |
| 09 Sep 2026 |
8-K: Results of Operations and Financial Condition; Other Events
San Ramon, Calif., September 9, 2026 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026. |
| 09 Sep 2026 | 10-Q |
| 06 Jul 2026 |
Form 4: Keel Paul A, Director
Granted 2,814 Restricted Stock Units |
| 06 Jul 2026 |
Form 3: Keel Paul A, Director
No securities owned |
| 05 Jun 2026 | 10-Q |
| 04 Jun 2026 | 8-K: Results of Operations and Financial Condition; Other Events |
| 29 May 2026 | SD |
| 14 May 2026 | SCHEDULE 13G/A |
| 04 May 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 29 Apr 2026 | SCHEDULE 13G |
| 21 Apr 2026 |
Form 4: Rosebrough Walter M Jr, Director
Granted 832 Restricted Stock Units · Received 832 shares by exercise or conversion |
| 08 Apr 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 06 Apr 2026 |
Form 4: Weiss Robert S, Director
Received 3,654 shares by exercise or conversion · Granted 3,779 Restricted Stock Units |
| 06 Apr 2026 |
Form 4: Rivas Maria, Director
Received 3,322 shares by exercise or conversion · Granted 3,779 Restricted Stock Units |
| 06 Apr 2026 |
Form 4: Jay Colleen, Director
Received 3,322 shares by exercise or conversion · Granted 4,157 Restricted Stock Units |
Loading...
